Biofidelity Announces Formation of Scientific Advisory Board

Biofidelity Ltd, the cancer diagnostics company, today announces the members of its newly-formed Scientific Advisory Board (SAB) with the appointments of leaders from the clinical, pharmaceutical and patient advocacy fields. Initial members include:

• Dr. Mace Rothenberg, former CMO, Pfizer
• Dr. Hesham Abdullah, Head of Oncology Global Clinical Development, GSK
• Dr. Jerald Radich, Professor & Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Research Center
• Andrea Conners, Executive Director, Patient Empowerment Network
• Phylicia L. Woods, Executive Director, Cancer Policy Institute, Cancer Support Community

Read more